Proteomics in brain research: potentials and limitations
- 1 February 2003
- journal article
- review article
- Published by Elsevier in Progress in Neurobiology
- Vol. 69 (3), 193-211
- https://doi.org/10.1016/s0301-0082(03)00036-4
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Proteomic profiling of mechanistically distinct enzyme classes using a common chemotypeNature Biotechnology, 2002
- Reduction of actin-related protein complex 2/3 in fetal Down syndrome brainBiochemical and Biophysical Research Communications, 2002
- Aberrant Expression of Centractin and Capping Proteins, Integral Constituents of the Dynactin Complex, in Fetal Down Syndrome BrainBiochemical and Biophysical Research Communications, 2002
- Manifold Reduction of Moesin in Fetal Down Syndrome BrainBiochemical and Biophysical Research Communications, 2001
- Decreased brain levels of 2′,3′-cyclic nucleotide-3′-phosphodiesterase in Down syndrome and Alzheimer’s diseaseNeurobiology of Aging, 2001
- Proteomic analysis of a developmentally regulated secretory vesicleProteomics, 2001
- Proteomic characterization of early-stage differentiation of mouse embryonic stem cells into neural cells induced byall-trans retinoic acidin vitroElectrophoresis, 2001
- Brain t-complex polypeptide 1 (TCP-1) related to its natural substrate β1 tubulin is decreased in Alzheimer's diseaseLife Sciences, 2001
- Differential expression of molecular chaperones in brain of patients with Down syndromeElectrophoresis, 2001
- Deranged Expression of Molecular Chaperones in Brains of Patients with Alzheimer's DiseaseBiochemical and Biophysical Research Communications, 2001